We engaged the Parkinson’s community by focusing on patients interested in genetics while prioritizing geographic areas underserved by existing recruitment methods, reaching active patients across 48 US states.
Patient coordinators led the conversations. Their initial goal was to relate to incoming patients, understand their needs, and connect them with resources that matched their journey. After establishing a connection and determining baseline eligibility, they shared information about the study and the genetic testing opportunity, then supported each patient through at-home genetic kits and site scheduling.
Those conversations built trust around genetic testing as a meaningful part of treatment planning. As patients learned that understanding their underlying Parkinson’s Disease could point toward better options, genetics became a much more prominent community topic.